Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study
Open Access
- 1 November 2017
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 153 (5), 1240-1250.e2
- https://doi.org/10.1053/j.gastro.2017.07.035
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index‐Daily Diary (GCSI‐DD)Neurogastroenterology & Motility, 2012
- Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General PopulationThe American Journal of Gastroenterology, 2012
- Similarities and Differences Between Diabetic and Idiopathic GastroparesisClinical Gastroenterology and Hepatology, 2011
- Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptyingNeurogastroenterology & Motility, 2010
- Development and content validity of a gastroparesis cardinal symptom index daily diaryAlimentary Pharmacology & Therapeutics, 2009
- The Incidence, Prevalence, and Outcomes of Patients With Gastroparesis in Olmsted County, Minnesota, From 1996 to 2006Gastroenterology, 2009
- Obesity Does Not Increase Effects of Synthetic Ghrelin on Human Gastric Motor FunctionsGastroenterology, 2006
- Drug Insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramideNature Clinical Practice Gastroenterology & Hepatology, 2006
- Prokinetics in Patients with Gastroparesis: A Systematic AnalysisDigestion, 1999
- Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).Gut, 1985